A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Dual TLR7/TLR9 Inhibitor HJ901 Inhibits ABC-DLBCL Expressing the MyD88 L265P Mutation

Published:2020-04-22 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

An Beiying,Zhu Shan,Li Tete,Wu Jing,Zang Guoxia,Lv Xinping,Qiao Yuan,Huang Jing,Shao Yan,Cui Jiuwei,Liu Yong-Jun,Chen Jingtao

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference43 articles.

1. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.;Barrat;J. Exp. Med.,2005

2. Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment.;Blonska;Blood,2015

3. Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463.;Camateros;Am. J. Respir. Crit. Care Med.,2007

4. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs.;Chen;Gene Ther.,2001

5. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.;Davis;J. Exp. Med.,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling;International Journal of Molecular Sciences;2023-03-15

2. The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies;Vaccines;2023-01-28

3. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges;Frontiers in Immunology;2022-11-21

4. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas;Cancer Discovery;2022-10-20

5. Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics;Disease Markers;2022-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3